Wellbutrin isnt suitable for everyone, and your healthcare provider will carefully review your health history before prescribing it
If weight gain specifically is a concern, a healthcare provider may recommend GLP-1s as part of your treatment plan
For anyone wondering how these 'peptides in skin' actually work or what 'dosage' means for a topical product, let me share my experience
Critical Considerations: This schedule is purely theoretical and not based on clinical evidence Individual tolerance varies dramaticallysome may not tolerate even these conservative doses Maximum combined doses would likely need to remain below monotherapy maximums (perhaps 2.4 mg cagrilintide + 8 mg retatrutide as absolute ceiling) Medical supervision would be essential throughout any such protocol Alternative Approach: Sequential Rather Than Concurrent An arguably safer alternative to simultaneous cagrilintide dosage with retatrutide administration involves sequential optimization: Optimize one compound first Reach stable, effective dose of either cagrilintide or retatrutide Assess response Evaluate metabolic effects over 12-16 weeks Introduce second compound Only if additional effects are needed Ultra-gradual second titration Even slower escalation of the added compound Continuous reassessment Regular evaluation of whether combination provides benefits beyond monotherapy This approach provides clearer attribution of effects and side effects to specific compounds, though it significantly extends the overall timeline
Regarding organ outcomes, our review indicates that, in high-risk populations, GLP-1RAs are associated with a 12-15% relative risk reduction in MACE and favorable effects on composite renal endpoints
